mDETECT · Liquid Biopsy

Transforming
Cancer Care
Through Ultra-Sensitive
Liquid Biopsy

Harnessing target-specific DNA methylation to deliver rapid, accurate, and accessible liquid biopsy tools that can track tumour burdens

Learn More Partner With Us

Explore mDETECT

mDETECT laboratory scientist working with a blood sample

Precision in every sample.

mDETECTLiquid Biopsy for Cancer Management

01 / The advantage

Why mDETECT?

Ultra-Sensitive Detection

where we can identify circulating tumor DNA (ctDNA) down to 0.01% LOD.

Multi-Cancer Test

with applications spanning Lung, Breast, Ovarian, Prostate and more.

Seamless Integration

across any platform and designed for rapid, automated NGS workflows to deliver analysis in minutes.

mDETECT liquid biopsy laboratory testing

From research to impact.

02 / Our purpose

Our Impact

At mDETECT, we are committed to advancing options for cancer patient monitoring. Using our innovative and advanced technology, we aim to provide oncologists with meaningful insights on cancer progression, relapse, and treatment response for each patient.

Learn More

03 / Explore mDETECT

Science. People. Progress.

Featured Research

Read the research behind the mDETECT cancer tests

Meet the Team

Our team's mission is to help extend the lives of patients battling metastatic cancer.

Latest News

Keep up with the latest at mDETECT

mDETECT Advances Methylation-Based Liquid Biopsy Assay on Thermo Fisher Scientific Ion Torrent™ Technology